Therapy of the Malignant Carcinoid Syndrome
Authors: CHARLES E. MENGEL
Journal: Annals of Internal Medicine (1965)

Review1 March 1965Therapy of the Malignant Carcinoid SyndromeCHARLES E. MENGEL, M.D.CHARLES E. MENGEL, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-62-3-587 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptThe therapy of the malignant carcinoid syndrome presents a unique challenge to physicians caring for patients with this unusual disease. All the problems inherent with any metastatic neoplastic process are compounded by the pharmacologic effects of excess serotonin production. Although a considerable amount of investigation has focused on the biochemical pathways involved in the "functioning" malignant carcinoid tumors, relatively little attention has been given to the total therapy of this disease. The infrequency of the disease, the limited experience of most physicians managing the isolated cases, and the variance of methods and parameters studied and methodology in different laboratories all...References1. MENGEL CE: Cutaneous manifestations of the malignant carcinoid syndrome: Severe pruritis and orange blotches. Ann. Intern. Med. 58: 989, 1963. LinkGoogle Scholar2. MENGELKELLYANLYAN CEMGWG: Clinical and biochemical effects of cyclophosphamide (CTX) in the malignant carcinoid syndrome (MCS). Proc. Amer. Ass. Cancer Res. 4: 43, 1963. Google Scholar3. MENGELKELLYCARBONEANLYAN CEMAPPWA: Clinical and biochemical effects of cyclophosphamide in patients with malignant carcinoid. Amer. J. Med. (in press). Google Scholar4. MENGELWEAVERHOLLOWAYANLYAN CEWLWG: Adjuvant therapy of the malignant carcinoid syndrome. Surgery 54: 182, 1963. Google Scholar5. DUNCANGARVENGIBBONS DJDJL: Argentaffin carcinoma of ileum with raised serum 5-hydroxytryptamine (serotonin); case. Brit. Med. J. 2: 1586, 1955. CrossrefMedlineGoogle Scholar6. ELDRED WJ: Argentaffin carcinomas; report of twenty-nine cases, six malignant. Arch. Surg. (Chicago) 73: 517, 1956. Google Scholar7. MACDONALD RA: A study of 356 carcinoids of the gastrointestinal tract. Amer. J. Med. 21: 867, 1956. CrossrefMedlineGoogle Scholar8. SJOERDSMAWEISSBACHUDENFRIEND AHS: A clinical, physiologic and biochemical study of patients with malignant carcinoid (argentaffinoma). Amer. J. Med. 20: 520, 1956. CrossrefMedlineGoogle Scholar9. SJOERDSMAWEISSBACHTERRYUDENFRIEND AHLLS: Further observations on patients with malignant carcinoid. Amer. J. Med. 23: 5, 1957. CrossrefMedlineGoogle Scholar10. ANLYANHARGROVERUFFINWALLACEWEAVERKIRSHNER WGMJMDKWTN: Metastasizing bronchial adenoma. Occurrence in patient with the functioning carcinoid syndrome. JAMA 174: 415, 1960. CrossrefMedlineGoogle Scholar11. LUPARELLOMCALLISTER FJJD: The association of metastasizing bronchial adenoma and the functioning carcinoid syndrome. Ann. Intern. Med. 54: 1266, 1961. LinkGoogle Scholar12. NITTERSKJORTEN HSF: (Carcinoid syndrome in a case of carcinoid tumor in the bronchus.) Nord. Med. 68: 1550, 1962. MedlineGoogle Scholar13. SCHNECKLOTHMCISAACPAGE REWMIH: Serotonin metabolism in carcinoid syndrome with metastatic bronchial adenoma. JAMA 170: 1143, 1959. CrossrefMedlineGoogle Scholar14. STANFORDDAVISGUNTERHOBART WRJEJUSA: Bronchial adenoma (carcinoid type) with solitary metastasis and associated functioning carcinoid syndrome. Southern Med. J. 51: 449, 1958. CrossrefMedlineGoogle Scholar15. WARNERSOUTHREN RRAL: Carcinoid syndrome produced by metastasizing adenoma. Amer. J. Med. 24: 903, 1958. CrossrefMedlineGoogle Scholar16. CHRISTODOUPOULASKLATZ JGAP: Carcinoid syndrome with primary carcinoid tumor of the stomach. Gastroenterology 40: 529, 1961. Google Scholar17. CIAMPA F: Carcinoids of the small bowel—report of a case in Meckel's diverticulum. Amer. J. Proctol. 12: 382, 1961. MedlineGoogle Scholar18. ELLIS FW: Carcinoid of the rectum; report of a case with thirteen years' survival; treated with intra-arterial nitrogen mustard. Cancer 10: 138, 1957. CrossrefMedlineGoogle Scholar19. LYKKEDELA LANDE AWIS: Carcinoid syndrome resulting from a malignant argentaffinoma in a Meckel's diverticulum. Med. J. Aust. 48: 125, 1961. CrossrefMedlineGoogle Scholar20. MCGREGOREISENBERGBACON JKSWHE: Carcinoid tumors of the rectum. JAMA 181: 552, 1962. CrossrefGoogle Scholar21. OATESSJOERDSMA JAA: A unique syndrome associated with secretion of 5-hydroxytryptophan by metastatic gastric carcinoids. Amer. J. Med. 32: 333, 1962. CrossrefMedlineGoogle Scholar22. SMITH AN: Carcinoid tumors. Proc. Roy. Soc. Med. 52: 24, 1959. CrossrefMedlineGoogle Scholar23. SIMPSONSTEWART JNI: Argentaffine tumour of the jejunum with perforation. Amer. J. Surg. 97: 784, 1959. CrossrefMedlineGoogle Scholar24. THORSONHANSONPERNOWSADERSTROMWALDENSTROMWINBLADWULFF AABNJSHB: Carcinoid tumor within an ovarian teratoma in a patient with the carcinoid syndrome (carcinoidosis); clinical picture and metabolic studies before and after total resection of tumor. Acta Med. Scand. 161: 495, 1958. CrossrefMedlineGoogle Scholar25. VAN WEEL MW: Carcinoid tumour of the ampulla of Vater. Arch. Chir. Neerl. 14: 15, 1962. MedlineGoogle Scholar26. IMRE J: (A case of intra-appendicular carcinoid tumor producing carcinoid syndrome with apparent clinical recovery after a surgical intervention.) Orv. Hetil. 103: 272, 1962. Google Scholar27. POLLOCK AV: Relief of flushing after resection of a secreting argentaffinoma. Brit. J. Surg. 46: 543, 1959. CrossrefMedlineGoogle Scholar28. DESJARDINSBEAUDOINGAREAUR ELAA: (Mesenteric thrombosis and carcinoid of the small intestine). Canad. J. Surg. 3: 156, 1960. MedlineGoogle Scholar29. EVANSMURPHY RWAF: Pseudomyxoma peritonei associated with an appendix obstructed by an argentaffinoma (carcinoid) in a male. Brit. J. Surg. 47: 166, 1959. CrossrefMedlineGoogle Scholar30. GALLAGHER WB: Carcinoid of the ileum producing intussusception: a case report. Wisconsin Med. J. 56: 251, 1957. MedlineGoogle Scholar31. KNOWLESSARLAWSLESENGER ODDHMH: Malabsorption syndrome associated with metastatic carcinoid tumor. Amer. J. Med. 27: 673, 1959. CrossrefMedlineGoogle Scholar32. MCCARTNEYSTEWART ETI: Argentaffin tumour with intussusception. Brit. Med. J. 5124: 769, 1959. CrossrefGoogle Scholar33. STARKBLUTHRUBENSTEIN SIS: Carcinoid tumor of the ileum resembling regional ileitis clinically and roentgenologically. Gastroenterology 40: 813, 1961. CrossrefGoogle Scholar34. STEWARTBARTLETTBISHOPCAMPBELLGOLDSMITHMACLEANMIDDLETONMUSSELMANRANNICKTAPPAN WHRMHMDANAKEAMGW: Carcinoid tumors presenting with acute abdominal signs. Ann. Surg. 154: Suppl. 112, 1961. Google Scholar35. WALDMANMARTINFERRIS EBWJDO: Carcinoid tumors of the small intestine; possible confusion of their manifestations with primary pancreatic or hepatic disease. Proc. Mayo Clin. 30: 127, 1955. MedlineGoogle Scholar36. ALPERT LI: An unusual case of intestinal bleeding—carcinoid tumor of the ileum; a report of a case. Brit. Med. Quart. 11: 12, 1960. Google Scholar37. GURNETTHARTIGAN TJJD: Small bowel carcinoids associated wth gastrointestinal bleeding. Nebraska Med. J. 45: 355, 1960. MedlineGoogle Scholar38. KLAUBER LD: Massive gastrointestinal hemorrhage due to carcinoid of the ileum. New York J. Med. 61: 3519, 1961. MedlineGoogle Scholar39. MANNSIMPSON LSRD: Carcinoid of the ileum; unusual cause of gastrointestinal bleeding. Arch. Surg. (Chicago) 75: 161, 1957. Google Scholar40. SCHOENFELDCOHANDYER RJR: Gastric carcinoid tumor. An unusual case of hematemesis. Arch. Intern. Med. (Chicago) 104: 649, 1959. CrossrefMedlineGoogle Scholar41. WILSON H: The malignant carcinoid syndrome: Massive liver resction for symptomatic relief. Amer. Surg. 25: 567, 1959. MedlineGoogle Scholar42. WILSONBUTTERICK HOD: Massive liver resection for control of severe vasomotor reactions secondary to malignant carcinoid. Ann. Surg. 149: 648, 1959. CrossrefMedlineGoogle Scholar43. KABAKOWWEINSTEINROSS BIBG: Clinical and metabolic studies of metastatic carcinoid. Amer. J. Med. 26: 636, 1959. CrossrefMedlineGoogle Scholar44. DAVISALEXANDERADICOFF RBCSA: Metabolic studies in carcinoid syndrome: Observations on use of a-methyl DOPA, isonicotinic acid hydrazide and selective tryptophan deficiency. Metabolism 10: 1035, 1961. MedlineGoogle Scholar45. COURSIN DB: Present status of Vitamin B6 metabolism. Amer. J. Clin. Nutr. 9: 304, 1961. CrossrefMedlineGoogle Scholar46. PRICEBROWNLARSON JMRRFC: Quantitative studies on human urinary metabolites of tryptophan as affected by isoniazid and hydroxypridoxine. J. Clin. Invest. 36: 1600, 1957. CrossrefMedlineGoogle Scholar47. REILLYKILLANJENNEYMARSHALLTANSIGAPTERPFEIFFER RHKFEHWHTNCC: Convulsant effects of isoniazid. JAMA 152: 1317, 1953. CrossrefMedlineGoogle Scholar48. VILTERMUELLERGLAZERJARROLDABRAHAMTHOMPSONHAWKINS RWJFHSTJCVR: The effect of Vitamin B6 deficiency induced by desoxypyridoxine in human beings. J. Lab. Clin. Med. 42: 335, 1953. MedlineGoogle Scholar49. LUDWIG GD: Inhibition of 5-hydroxyindoleacetic acid (5-HIAA) excretion by isonicotinic acid hydrazide (INH) in patient with malignant carcinoid. Clin. Res. 8: 30, 1960. Google Scholar50. SCHRODTDIZONPESKOEHOWELLROBIESTEVENSON GRFYLYRSCHTD: The effect of pyridoxine antagonists in the carcinoid syndrome. Amer. Pract. 11: 750, 1960. Google Scholar51. COLLINI FJ: Use of alpha-methyl-dopa (alpha-methyl-3, 4-dihydroxy-DL-phenylalanine) in the management of the carcinoid syndrome. New Eng. J. Med. 264: 986, 1961. CrossrefMedlineGoogle Scholar52. GIFFROYCARTIERLEMOINEFABLETMOREAUMALANDRINLEGRAND YPPJJCM: (Trial of alpha-methyl-DOPA in a case of carcinoidosis). Path. Biol. 10: 75, 1962. MedlineGoogle Scholar53. HAGEN P: Observations on the substrate specificity of DOPA decarboxylase from an adrenal medulla, human phaeochromocytoma, and human argentaffinoma. Brit. J. Pharmacol. 18: 175, 1962. Google Scholar54. NICHOLSONIRVINE GIRO: Effect of methyl DOPA in carcinoid disease. Brit. Med. J. 53: 961, 1962. CrossrefGoogle Scholar55. NOBLE NR: A case of carcinoid syndrome with an account of the use of alpha-methyl-dopa. Med. J. Aust. 52: 589, 1961. CrossrefGoogle Scholar56. SANDLERSNOW MPJ: An atypical carcinoid tumour secreting 5-hydroxytryptophan. Lancet 1: 137, 1958. CrossrefMedlineGoogle Scholar57. SJOERDSMAOATESZALTSMANUDENFRIEND AJAPS: Serotonin synthesis in carcinoid patients. Its inhibition by a-methyl-dopa, with measurement of associated increases in urinary 5-hydroxytryptophan. New Eng. J. Med. 263: 585, 1960. CrossrefMedlineGoogle Scholar58. WALDENSTROMPERNOWSILVER JBH: Case of metastasizing carcinoma (argentaffinoma?) of unknown origin showing peculiar red flushing and increased amounts of histamine and 5-hydroxytryptamine in blood and urine. Acta Med. Scand. 156: 73, 1956. CrossrefMedlineGoogle Scholar59. WALTIDREUXBONVARLETSAVIERDUHAMEL JJCACHJ: (Trial treatment of 2 cases of carcinoid syndrome with a-methyl-dopa.) Bull. Soc. Med. Hop. Paris 113: 804, 1962. MedlineGoogle Scholar60. LEVINESJOERDSMA RJA: Pressor amines and the carcinoid flush. Ann. Intern. Med. 58: 818, 1963. LinkGoogle Scholar61. OATESMELMANSJOERDSMAGILLESPIEMASON JAKALDT: Release of a kinin peptide in the carcinoid syndrome. Lancet 1: 514, 1964. CrossrefMedlineGoogle Scholar62. PEARTROBERTSONANDREWS WSJITM: Facial flushing produced in patients with carcinoid syndrome by intravenous adrenaline and noradrenaline. Lancet 2: 715, 1959. CrossrefMedlineGoogle Scholar63. ROBERTSONPEARTANDREWS JIWSTM: The mechanism of facial flushes in the carcinoid syndrome. Quart. J. Med. 31: 103, 1962. MedlineGoogle Scholar64. BROWNHILLBERRYBING RESRKWRJ: Studies on several possible antiserotonin compounds in functioning carcinoid syndrome. Clin. Res. 8: 61, 1960. CrossrefGoogle Scholar65. DUBACHGSELL UCOR: Carcinoid syndrome. Effective symptomatic treatment. Amer. Heart J., 65: 425, 1963. CrossrefGoogle Scholar66. PEARTROBERTSON WSJI: The effect of a serotonin antagonist (UML-491) in carcinoid disease. Lancet 2: 1172, 1961. CrossrefMedlineGoogle Scholar67. RESNICKGRAY RHSJ: Serontonin metabolism and carcinoid syndrome: Review. Med. Clin. N. Amer. 44: 1323, 1960. CrossrefMedlineGoogle Scholar68. SCHNECKLOTHPAGEDEL GRECOCORCORAN RIHFAC: Effects of serotonin antagonists in normal subjects and patients with carcinoid tumors. Circulation 16: 523, 1957. CrossrefMedlineGoogle Scholar69. URELESMURRAYWOLF ALMR: Results of pharmacologic treatment in the malignant carcinoid syndrome. New Eng. J. Med. 267, 435, 1962. CrossrefMedlineGoogle Scholar70. VROOMBROWNDEMPSEYHILL FQREJSR: Studies of several possible antiserotonin compounds in a patient with functioning carcinoid syndrome. Ann. Intern. Med. 56: 941, 1962. LinkGoogle Scholar71. WEAVERMETZANLYANRUNDLES WTENWGWR: The use of serotonin antagonists in the treatment of the malignant carcinoid syndrome. Surg. Forum 12: 330, 1961. MedlineGoogle Scholar72. DANIELL HW Vasospastic reaction to methysergide maleate simulating Leriche syndrome: Ineffective treatment with adrenergic blockade. Ann. Intern. Med. 60: 881, 1964. LinkGoogle Scholar73. COLEMATTHEWS JWLM: Distribution of radioactive tryphtophan in a patient with metastatic carcinoid. Arch. Surg. (Chicago) 76: 912, 1958. CrossrefGoogle Scholar74. ROTH M: Carcinoid of the rectum. A case report with observations on radiosensitivity of nodular metastases to the skin. Amer. J. Roentgen. 84: 97, 1961. Google Scholar75. SAUERDEARINGFLOCK WGWHEV: Diagnosis and clinical management of functioning carcinoids. JAMA 168: 139, 1958. CrossrefMedlineGoogle Scholar76. VAETHROUSSEAUPURCELL JMRETR: Radiation response of carcinoid of the rectum. Amer. J. Roentgen. 88: 967, 1962. Google Scholar77. ELLIS FW: Carcinoid of the rectum: report of case of thirteen years survival: treated with intra-arterial nitrogen mustard. Cancer 10: 138, 1957. CrossrefMedlineGoogle Scholar78. JEFFRIESBARRETTPITTMAN JLJCJA: Medical grand rounds. Southern Med. J. 56: 711, 1963. CrossrefMedlineGoogle Scholar79. KNOEPPKASTLRAYBURNSAYEGHLETSON LFWHALSFWM: Clinical experience with 5-fluorouracil. Cancer Chemother. Rep. 12: 89, 1961. MedlineGoogle Scholar80. MOERTELREITEMEIER CGRJ: Experience with 5-fluorouracil in palliative management of advanced carcinoma of gastrointestinal tract. Proc. Mayo Clin. 37: 520, 1962. Google Scholar81. ROCHLINSHINERLANGDONOTTOMAN DBJER: Use of 5-fluorouracil in disseminated solid neoplasms. Ann. Surg. 156: 105, 1962. CrossrefMedlineGoogle Scholar82. MENGEL CE: Biochemical and morphologic heterogeneity and variability of mast cell neoplasms in vivo. Ann. NY Acad. Sci. 103: 225, 1963. CrossrefGoogle Scholar83. MENGELKELLY CEMG: Biochemical and morphologic changes in a mast cell tumor during treatment with cyclophosphamide. Proc. Amer. Ass. Cancer Res. 3: 250, 1961. Google Scholar84. MENGELKELLY CEMG: Biochemical and morphologic changes in a mast cell neoplasm during treatment with cyclophosphamide. Cancer Res. 21: 1545, 1961. MedlineGoogle Scholar85. REEDKNIFERSVAITKEVICUSCLARKDRAKEEYLER MLFMVKMDEHWR: Treatment of disseminated carcinoid tumors including hepatic-artery catheterization. New Eng. J. Med. 269: 1005, 1963. CrossrefMedlineGoogle Scholar86. AUSTERNJOHANSSONLUNDBERGSJOBERG HSAAHE: Heparin treatment in a case of carcinoid tumour. Acta Med. Scand. 168: 367, 1960. CrossrefMedlineGoogle Scholar87. BENDITTROWLEY EPDA: Antagonism of 5-hydroxytryptamine by chlorpromazine. Science 123: 24, 1956. CrossrefMedlineGoogle Scholar88. COLEBERTINO JWGG: Effect of chlorpromazine on excretion of 5-hydroxyindoleacetic acid in a patient with malignant carcinoid. Proc. Soc. Exp. Biol. Med. 93: 100, 1956. CrossrefMedlineGoogle Scholar89. DUBACHGSELL UCOR: Carcinoid syndrome: Alleviation of diarrhea and flushing with "Deseril" and RO5-1025. Brit. Med. J. 5289: 1390, 1962. CrossrefGoogle Scholar90. SANDLERCLOSE MHG: Biochemical effect of phenylacetic acid in a patient with 5-hydroxytryptamine-secreting carcinoid tumor. Lancet 2: 316, 1959. CrossrefMedlineGoogle Scholar91. SANDLERDAVIESRIMINGTON MAG: Effect of phenylacetic acid on the carcinoid syndrome. Lancet 2: 318, 1959. CrossrefMedlineGoogle Scholar92. SAUERDEARINGFLOCK WGWHEV: Diagnosis and clinical management of functioning carcinoids. JAMA 168: 139, 1958. CrossrefMedlineGoogle Scholar93. CHRISTIANCURRENS JJJH: The carcinoid syndrome and related cardiac disease: report of a case with predominant tricuspid disease. New Eng. J. Med. 260: 629, 1959. CrossrefMedlineGoogle Scholar94. MATTINGLYSJOERDSMA TWA: Cardiovascular manifestations of functioning carcinoid tumors. Mod. Conc. Cardiov. Dis. 25: 337, 1956. MedlineGoogle Scholar95. ROBERTSSJOERDSMA WCA: The cardiac disease associated with the carcinoid syndrome. Amer. J. Med. 36: 5, 1964. CrossrefMedlineGoogle Scholar96. STEELE CW: Malignant carcinoid. Metastasis to skin and production of carcinoid syndrome, hypertension, diarrhea, dementia, and hypopotasemia, a case report. Arch. Intern. Med. (Chicago) 110: 763, 1962. CrossrefMedlineGoogle Scholar97. SCHWABERLUKAS JRDS: Hyperkinemia and cardiac failure in the carcinoid syndrome. Amer. J. Med. 32: 846, 1962. CrossrefMedlineGoogle Scholar98. WRIGHTMULDER PWDA: Carcinoid heart disease. Amer. J. Cardiol. 12: 864, 1963. CrossrefMedlineGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAuthors: CHARLES E. MENGEL, M.D.Affiliations: Durham, North CarolinaFrom the Department of Medicine, Duke University Medical Center, Durham, N. C.This work was supported by Research Grant CA-O 6452 from the U. S. Public Health Service, Bethesda, Md.Dr. Mengel is a John and Mary Markle Scholar in Academic Medicine.Requests for reprints should be addressed to Charles E. Mengel, M.D., Department of Medicine, Duke University, Durham, N. C. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byA case of middle ear adenoma suspected as glomus tumorA Case of Carcinoid Tumor of the Middle EarA Case of Carcinoid Tumor of the Middle EarCancer of the Endocrine SystemIntestinal ischaemia associated with ileal carcinoid tumoursCarcinoid Tumours and the Carcinoid SyndromeTissue HormonesSmall bowel carcinoid tumorsThe pulmonary Kulchitsky cell (neuroendocrine) cancers: From carcinoid to small cell carcinomasTryptophan in the treatment of carcinoid crisisEndokrine Tumoren des DünndarmsHormonell induzierte DiarrhöenSerotonin Depletion by Fenfluramine in the Carcinoid SyndromePalliation of malignant disease of the gastrointestinal tractTamoxifen in Carcinoid SyndromeChemotherapy for the carcinoid syndromeTumors of the small intestineManagement of carcinoid syndromeGewebehormoneCarcinoid syndrome: its relevance to the anaesthetistEndocrine TumorsPrimary Carcinoid Tumor of the UrethraNatural History and Diagnosis of the Carcinoid SyndromeThe Cytostatic Therapy of Hormone Secreting Tumours of the GI TractA Carcinoid SagaTissue HormonesChemotherapeutic management of the hormone-secreting endocrine malignanciesThe Carcinoid Syndrome—20 Years onAirways Obstruction in the Carcinoid Syndrome a Study of the Effect of Drugs and other FactorsThe carcinoidCarcinoid and Adenoid Cystic Carcinoma of the BronchusCarcinoid tumorsProgress report: the carcinoid syndrome.CARCINOID TUMORS AND THE CARCINOID SYNDROMETHE CONTROL OF FLUSHING AND DIARRHŒA IN CARCINOID SYNDROME BY AN ANTI‐SEROTONIN AGENT, BC105Unerwarteter Tod bei malignem CarcinoidTreatment of Gastrointestinal Cancer: Current Status and Recent ProgressGastrointestinal Carcinoids and the Carcinoid Syndrome: Clinical Characteristics and TherapyANTAGONISM BY METHYSERGIDE OF VASCULAR EFFECTS OF 5-HYDROXYTRYPTAMINE IN MANPharmacologic and Endocrine Aspects of Carcinoid SyndromeThe Effect of Pyridoxine Deficiency on Carcinoid Syndrome Study of a Case of Metastatic Bronchial Adenoma Treated with Induced Vitamin B6 DeficiencySALMAN GAILANI, M.B., AUGUSTINE L. ROQUE, M.D., JAMES F. HOLLAND, M.D.Isolated tricuspid insufficiency 1 March 1965Volume 62, Issue 3 Page: 587-602 Keywords Academic medicine Carcinoid tumor Malignant tumors Medical services Research grants Serotonin ePublished: 1 December 2008 Issue Published: 1 March 1965 PDF downloadLoading ...